Evidence map›Paper›PMID 27439313›Full record

ArticleHuman gene therapy2016

Highly Efficient Delivery of Adeno-Associated Viral Vectors to the Primate Retina.

Shannon E Boye, John J Alexander, C Douglas Witherspoon, Sanford L Boye, James J Peterson, Mark E Clark, Kristen J Sandefer, Chris A Girkin, William W Hauswirth, Paul D Gamlin

Abstract read
In one paragraph

Article in Human gene therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Recombinant adeno-associated virus as a delivery platform for ocular gene therapy: A comprehensive review.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Lentiviral delivered aflibercept OXB-203 for treatment of neovascular AMD.Molecular therapy. Methods & clinical development · 2023
    Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Shannon E Boye1 Department of Ophthalmology, University of Florida College of Medicine , Gainesville, Florida.
John J Alexander2 Department of Human Genetics, Emory University , Atlanta, Georgia.
C Douglas Witherspoon3 Department of Ophthalmology, University of Alabama at Birmingham , Birmingham, Alabama.
Sanford L Boye1 Department of Ophthalmology, University of Florida College of Medicine , Gainesville, Florida.
James J Peterson1 Department of Ophthalmology, University of Florida College of Medicine , Gainesville, Florida.
Mark E Clark3 Department of Ophthalmology, University of Alabama at Birmingham , Birmingham, Alabama.
Kristen J Sandefer4 Department of Neurology, University of Alabama at Birmingham , Birmingham, Alabama.
Chris A Girkin3 Department of Ophthalmology, University of Alabama at Birmingham , Birmingham, Alabama.
William W Hauswirth1 Department of Ophthalmology, University of Florida College of Medicine , Gainesville, Florida.
Paul D Gamlin3 Department of Ophthalmology, University of Alabama at Birmingham , Birmingham, Alabama.
University of Alabama at Birmingham · USFlorida College · USEmory University · USUniversity of Florida · US

Funding

UAB CENTER FOR CLINICAL AND TRANSLATIONAL SCIENCE (CCTS) UL1: BPCAUL1RR025777 · NCRR · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUAY-WOODFORD, LISA MARIE · 2008 to 2011
$22.3M
Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LAWRENCE C SINCICH · 1985 to 2026
$16.9M
Engineering AAV for safe and efficient gene delivery to the human retinaR01EY024280 · NEI · UNIVERSITY OF FLORIDA · PI Shannon Elizabeth Boye · 2014 to 2026
$7.5M
Intrinsically photosensitive retinal ganglion cells and their central projectionsR01EY025555 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DO, MICHAEL TRI HOANG, GAMLIN, PAUL DOUGLAS · 2016 to 2020
$3.9M
Vision Research CoreP30EY021721 · NEI · UNIVERSITY OF FLORIDA · PI HAUSWIRTH, WILLIAM W · 2011 to 2015
$2.8M
NCRR NIH HHS UL1 RR025777NEI NIH HHS P30 EY003039NEI NIH HHS P30 EY021721NEI NIH HHS R01 EY024280NEI NIH HHS R01 EY025555
6 · The paper itself

Abstract

Adeno-associated virus (AAV) has emerged as the preferred vector for targeting gene expression to the retina. Subretinally injected AAV can efficiently transduce retinal pigment epithelium and photoreceptors in primate retina. Inner and middle primate retina can be transduced by intravitreally delivered AAV, but with low efficiency. This is due to dilution of vector, potential neutralization of capsid because it is not confined to the immune-privileged retinal compartment, and the presence of the inner limiting membrane (ILM), a barrier separating the vitreous from the neural retina. We here describe a novel "subILM" injection method that addresses all three issues. Specifically, vector is placed in a surgically induced, hydrodissected space between the ILM and neural retina. In an initial experiment, we injected viscoelastic (Healon(®)), a substance we confirmed was biocompatible with AAV, to create a subILM bleb and subsequently injected AAV2-GFP into the bleb after irrigation with basic salt solution. For later experiments, we used a Healon-AAV mixture to place single, subILM injections. In all cases, subILM delivery of AAV was well tolerated-no inflammation or gross structural changes were observed by ophthalmological examination or optical coherence tomography. In-life fluorescence imaging revealed profound transgene expression within the area of the subILM injection bleb that persisted for the study duration. Uniform and extensive transduction of retinal ganglion cells (RGCs) was achieved in the areas beneath the subILM bleb. Transduction of Müller glia, ON bipolar cells, and photoreceptors was also observed. Robust central labeling from green fluorescent protein-expressing RGCs confirmed their continued survival, and was observed in the lateral geniculate nucleus, the superior colliculus, and the pretectum. Our results confirm that the ILM is a major barrier to transduction by AAV in primate retina and that, when it is circumvented, the efficiency and depth to which AAV2 promotes transduction of multiple retinal cell classes are greatly enhanced.

Indexed as

AnimalsDependovirusGenetic VectorsGreen Fluorescent ProteinsMacaca nemestrinaMaleRetinaRetinal Ganglion CellsTransduction, GeneticTransgenesGreen Fluorescent Proteins

Identifiers

PMID27439313
PMCPMC4991591
OpenAlexW2495536352

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.